Future studies will investigate the role of FGF23 in stimulating expression of Runx2 and Runx2 target genes and enhancing transcriptional activity of Runx2 leading to increased biogenesis of tumor supportive EMVs that drive the vicious cycle and contribute to vitamin D deficiency. Here, RUNX2 is linked to neoplasm.